View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: June 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 17, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Illumina Inc: 2 directors

Two Directors at Illumina Inc bought 18,450 shares at between 80.864USD and 81.210USD. The significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Illumina, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 10 April 2025 in which we reassessed the appropriateness of the ratings in the context of th...

Moody's Ratings assigns Baa3 rating to Illumina's sr. unsecured notes

Moody's Ratings (Moody's) assigned a Baa3 rating to the new senior unsecured notes offering of Illumina, Inc. ("Illumina"). In addition, we assigned a (P)Baa3 rating to Illumina's new senior unsecured shelf registration statement. There are no changes to Illumina's existing Baa3 senior unsecured not...

Illumina, Inc.: Update following outlook revision to stable from negat...

Our credit view of this issuer reflects its solid margins and free cash flow, constrained by its very high concentration in one business segment.

Illumina, Inc.: Update following outlook revision to stable from negat...

Our credit view of this issuer reflects its solid margins and free cash flow, constrained by its very high concentration in one business segment.

Moody's Ratings affirms Illumina's Baa3 rating; revises outlook to sta...

Moody's Ratings (Moody's) affirmed the Baa3 issuer rating and senior unsecured ratings of Illumina, Inc. ("Illumina"). At the same time, Moody's revised the outlook to stable from negative. The revision of the outlook to stable reflects reduced negative pressure on Illumina's credit profile becaus...

Illumina, Inc.: Update following outlook revision to negative

Our credit view of this issuer reflects its long standing client relationships, offset by its significant operating losses at GRAIL.

Moody's revises Illumina's outlook to negative; affirms Baa3 rating

Moody's Investors Service ("Moody's") has revised the outlook of Illumina, Inc. ("Illumina") to negative from stable. Concurrently, Moody's affirmed Illumina's Baa3 issuer and senior unsecured ratings. The revision of the outlook to negative reflects Moody's expectation that Illumina will operate ...

Moody's assigns Baa3 rating to Illumina's notes offering

Moody's Investors Service, ("Moody's") assigned a Baa3 rating to the proposed offering of $1 billion of senior unsecured notes of Illumina, Inc ("Illumina"). There are no changes to Illumina's existing Baa3 issuer rating or the stable outlook. Proceeds of the offering will be used to repay upcomin...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Moody's says $334 million adverse verdict in patent case is credit neg...

Moody's Investors Service commented that the adverse verdict in a patent infringement lawsuit is credit negative but manageable for Illumina, Inc. Despite its large amount ($334 million), Illumina is in a position to absorb this large adverse monetary award thanks to $1.35 billion of cash on hand an...

Illumina, Inc.: $334 million adverse verdict in patent case is credit ...

While the damages award is large, we believe Illumina can absorb it due to its sizeable cash balances and free cash flow generation. Illumina plans to appeal the decision.

Illumina, Inc.: Strong growth set to continue in 2022 but GRAIL's long...

Our credit view of this issuer reflects its long standing client relationships, constrained by its significant GRAIL losses.

Thanks to a better fundamental star rating, ILLUMINA sees an upgrade t...

The independent financial analyst theScreener just awarded an improved star rating to ILLUMINA (US), active in the Biotechnology industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 2 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as moderately risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date March 18, 2022, the closi...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch